Weiss Ratings Reiterates Sell (D) Rating for Envista (NYSE:NVST)

Key Points

• Weiss Ratings has reiterated a "Sell (D)" rating for Envista Holdings Corporation (NYSE: NVST), indicating negative sentiment among analysts towards the stock.
• Envista's stock price target has been revised by several firms, with Evercore ISI setting it at $25.00, while Wells Fargo raised it to $19.00, reflecting mixed outlooks on the company's performance.
• The company reported $0.26 in earnings per share for its last quarter, surpassing expectations and showing a 7.7% year-over-year revenue increase.

Envista (NYSE:NVST - Get Free Report)'s stock had its "sell (d)" rating reiterated by stock analysts at Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

NVST has been the subject of several other research reports. Evercore ISI set a $25.00 price target on Envista in a report on Wednesday. Stifel Nicolaus boosted their price target on Envista from $24.00 to $25.00 and gave the company a "buy" rating in a report on Friday, August 1st. Wells Fargo & Company boosted their price target on Envista from $17.00 to $19.00 and gave the company an "equal weight" rating in a report on Friday, August 1st. Mizuho upped their price objective on Envista from $15.00 to $18.00 and gave the stock an "underperform" rating in a research note on Friday, August 1st. Finally, Zacks Research lowered Envista from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 15th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $21.08.

Envista Stock Performance

NYSE:NVST opened at $20.58 on Wednesday. The stock has a 50-day simple moving average of $20.72 and a two-hundred day simple moving average of $18.93. Envista has a 52-week low of $14.22 and a 52-week high of $23.00. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.08 and a current ratio of 2.44. The firm has a market capitalization of $3.42 billion, a PE ratio of 64.31, a P/E/G ratio of 1.09 and a beta of 1.01.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. Envista had a return on equity of 4.84% and a net margin of 2.11%.The business had revenue of $682.10 million during the quarter, compared to analyst estimates of $638.21 million. During the same quarter in the previous year, the company posted $0.11 earnings per share. Envista's revenue for the quarter was up 7.7% on a year-over-year basis. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. Analysts forecast that Envista will post 1 EPS for the current year.

Hedge Funds Weigh In On Envista

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. UMB Bank n.a. boosted its stake in Envista by 214.4% during the first quarter. UMB Bank n.a. now owns 2,094 shares of the company's stock valued at $36,000 after buying an additional 1,428 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company's stock valued at $44,000 after purchasing an additional 949 shares during the period. EverSource Wealth Advisors LLC raised its position in Envista by 378.0% during the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company's stock valued at $47,000 after purchasing an additional 1,909 shares during the period. GAMMA Investing LLC raised its position in Envista by 34.3% during the third quarter. GAMMA Investing LLC now owns 2,498 shares of the company's stock valued at $51,000 after purchasing an additional 638 shares during the period. Finally, Parallel Advisors LLC raised its position in Envista by 100.1% during the second quarter. Parallel Advisors LLC now owns 2,792 shares of the company's stock valued at $55,000 after purchasing an additional 1,397 shares during the period.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.